Interaction of an atypical Plasmodium falciparum ETRAMP with human apolipoproteins

Department of Genome Sciences, University of Washington, Box 355065, Seattle, WA 98195, USA.
Malaria Journal (Impact Factor: 3.11). 11/2008; 7(1):211. DOI: 10.1186/1475-2875-7-211
Source: PubMed


In order to establish a successful infection in the human host, the malaria parasite Plasmodium falciparum must establish interactions with a variety of human proteins on the surface of different cell types, as well as with proteins inside the host cells. To better understand this aspect of malaria pathogenesis, a study was conducted with the goal of identifying interactions between proteins of the parasite and those of its human host.
A modified yeast two-hybrid methodology that preferentially selects protein fragments that can be expressed in yeast was used to conduct high-throughput screens with P. falciparum protein fragments against human liver and cerebellum libraries. The resulting dataset was analyzed to exclude interactions that are not likely to occur in the human host during infection.
An initial set of 2,200 interactions was curated to remove proteins that are unlikely to play a role in pathogenesis based on their annotation or localization, and proteins that behave promiscuously in the two-hybrid assay, resulting in a final dataset of 456 interactions. A cluster that implicates binding between P. falciparum PFE1590w/ETRAMP5, a putative parasitophorous vacuole membrane protein, and human apolipoproteins ApoA, ApoB and ApoE was selected for further analysis. Different isoforms of ApoE, which are associated with different outcomes of malaria infection, were shown to display differential interactions with PFE1590w.
A dataset of interactions between proteins of P. falciparum and those of its human host was generated. The preferential interaction of the P. falciparum PFE1590w protein with the human ApoE epsilon3 and ApoE epsilon4 isoforms, but not the ApoE epsilon2 isoform, supports the hypothesis that ApoE genotype affects risk of malaria infection. The dataset contains other interactions of potential relevance to disease that may identify possible vaccine candidates and drug targets.

Download full-text


Available from: Sudhir Sahasrabudhe,
  • Source
    • "Antigens to assess IFN-γ production were chosen based on reported findings in the literature; they were either a) pre-erythrocytic liver and blood stage antigens previously assessed for vaccine induced T cell immunogenicity (MSP, [31], [32] AMA, [32], [33] TRAP, [34] Pfs16, STRAP, EXP1, LSA1 [35]), b) targets of immune responses in naturally exposed individuals or volunteers vaccinated with irradiated sporozoites (CelTOS, [26] Exp1, [36], [37], LSA1 [24], [38] and LSA3 [39], STARP [40], Pfs16 [41]), c) proteins known to have protective homologs based on murine or non-human primate sub-unit vaccination studies (CelTOS, [42] Exp1, [43] LSA3, [36], [44] PfUIS3, [45] PFI0580c [45]), or d) proteins recently identified as highly up-regulated during the liver-stage (LSAP1, [46] LSAP2 [46] and PFE1590w). [47]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Controlled human malaria infection (CHMI) studies have become a routine tool to evaluate efficacy of candidate anti-malarial drugs and vaccines. To date, CHMI trials have mostly been conducted using the bite of infected mosquitoes, restricting the number of trial sites that can perform CHMI studies. Aseptic, cryopreserved P. falciparum sporozoites (PfSPZ Challenge) provide a potentially more accurate, reproducible and practical alternative, allowing a known number of sporozoites to be administered simply by injection. We sought to assess the infectivity of PfSPZ Challenge administered in different dosing regimens to malaria-naive healthy adults (n = 18). Six participants received 2,500 sporozoites intradermally (ID), six received 2,500 sporozoites intramuscularly (IM) and six received 25,000 sporozoites IM. Five out of six participants receiving 2,500 sporozoites ID, 3/6 participants receiving 2,500 sporozoites IM and 6/6 participants receiving 25,000 sporozoites IM were successfully infected. The median time to diagnosis was 13.2, 17.8 and 12.7 days for 2,500 sporozoites ID, 2,500 sporozoites IM and 25,000 sporozoites IM respectively (Kaplan Meier method; p = 0.024 log rank test). 2,500 sporozoites ID and 25,000 sporozoites IM have similar infectivities. Given the dose response in infectivity seen with IM administration, further work should evaluate increasing doses of PfSPZ Challenge IM to identify a dosing regimen that reliably infects 100% of participants. NCT01465048.
    PLoS ONE 06/2013; 8(6):e65960. DOI:10.1371/journal.pone.0065960 · 3.23 Impact Factor
  • Source
    • "Vignali et al. (28) used a modified yeast two-hybrid methodology to identify interactions between P. falciparum proteins and those of its human host. They identified 456 interactions after filtering their data to reduce likely false-positives. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Molecular interactions between a parasite and its host are key to the ability of the parasite to enter the host and persist. Our understanding of the genes and proteins involved in these interactions is limited. To better understand these processes it would be advantageous to have a range of methods to predict pairs of genes involved in such interactions. Correlated gene expression profiles can be used to identify molecular interactions within a species. Here we have extended the concept to different species, showing that genes with correlated expression are more likely to encode proteins, which directly or indirectly participate in host-parasite interaction. We go on to examine our predictions of molecular interactions between the malaria parasite and both its mammalian host and insect vector. Our approach could be applied to study any interaction between species, for example, between a host and its parasites or pathogens, but also symbiotic and commensal pairings.
    Nucleic Acids Research 12/2012; 41(3). DOI:10.1093/nar/gks1340 · 9.11 Impact Factor
  • Source
    • "The life cycle of this parasite in the human host includes the developmental cycle in the red blood cells (RBC), and then the transformation cycle in the liver cell parenchyma. P. falciparum has been found to establish successful infection in human host by interacting with a variety of human proteins on the surface of the different cell types, as well as those in the cells of the host [3] [4] . Other biochemical events that have been reported to occur in malaria include cellular changes in energy metabolism, hemo metabolism, membrane lipid peroxidation (LPO) and stress enzymes [5] . "
    [Show abstract] [Hide abstract]
    ABSTRACT: To investigate the relationship between malaria parasite status and cholesterol level of 110 consenting subjects (55 patients and 55 controls) in parts of the Imo River Basin of Nigeria. Giemsa staining was used for malaria parasite examination while Randox cholesterol kit was used for cholesterol level estimation. About 49 persons (90%) with malaria had low cholesterol (<180 mg/dL). Highest mean cholesterol levels were 274 mg/dL for study patients and 220 mg/dL for controls respectively; Lowest mean cholesterol levels were 168 mg/dL (patients) and 138 mg/dL (controls) respectively. Low cholesterol levels (<180 mg/dL) were found in patients (84%) and controls (6%) respectively. However, 16.4% of controls and 6% of patients had borderline cholesterol level (200-239 mg/dL). This study establishes a significant correlation (12.9%, P<0.01) between malaria parasite status and cholesterol level. These findings imply that cholesterol level estimation may be a potential concurrent and valuable diagnosis for malaria status.
    Asian Pacific Journal of Tropical Medicine 12/2011; 4(12):993-6. DOI:10.1016/S1995-7645(11)60232-0 · 0.93 Impact Factor
Show more